A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer

Vascular endothelial growth factor (VEGF) is expressed in human bladder tumors. A phase II study was conducted to assess the VEGF inhibitor pazopanib in patients with metastatic, urothelial carcinoma. Nineteen patients with one prior systemic therapy were enrolled. No objective responses were observ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pili, Roberto, Qin, Rui, Flynn, P.J., Picus, Joel, Millward, Michael, Ho, Wing Ming, Pitot, Henry, Tan, Winston, Miles, Kiersten M., Erlichman, Charles, Vaishampayan, Ulka
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4102930/
https://ncbi.nlm.nih.gov/pubmed/23891158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2013.05.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados